Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2291]
News [4645]
Articles [192]
Editorials [8]
Conferences [136]
elearning [9]
Pacritinib versus best available therapy for low platelet Myelofibrosis
Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA
Pacritinib versus best available therapy for low platelet Myelofibrosis ( Dr John Mascarenhas - Mount Sinai School of Medicine New York, USA )
6 Dec 2016
ASH 2016 highlights: breaking new ground in haematology
Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy
ASH 2016 highlights: breaking new ground in haematology ( Dr Giovanni Martinelli - Università di Bologna, Bologna, Italy )
6 Dec 2016
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML...
Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA
TCA cycle inhibition by CPI-613 increases chemo sensitivity in older AML patients ( Dr Timothy Pardee - Wake Forest Baptist Medical Center, Winston-Salem, USA )
6 Dec 2016
Azacitidine plus nivolumab against acute myeloid leukaemia
Prof Naval Daver - MD Anderson Cancer Center, Houston, USA
Azacitidine plus nivolumab against acute myeloid leukaemia ( Prof Naval Daver - MD Anderson Cancer Center, Houston, USA )
6 Dec 2016
Highlights in myeloid leukaemia research from ASH 2016
Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy
Highlights in myeloid leukaemia research from ASH 2016 ( Dr Luca Mazzarella - European Institute of Oncology, Milan, Italy )
5 Dec 2016
Clinical updates for guadecitabine and vorinostat
Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA
Clinical updates for guadecitabine and vorinostat ( Dr Guillermo Montalbán Bravo - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Pracinostat and azacitidine for elderly AML
Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA
Pracinostat and azacitidine for elderly AML ( Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA )
5 Dec 2016
Ibrutinib in CLL: RESONATE and resistance
Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA
Ibrutinib in CLL: RESONATE and resistance ( Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA )
4 Dec 2016
Vadastuximab talirine in combination for newly diagnosed AML
Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA
Vadastuximab talirine in combination for newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )
3 Dec 2016
Novel antibody boosts responses in newly diagnosed AML
Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA
Novel antibody boosts responses in newly diagnosed AML ( Prof Harry Erba - UAB Comprehensive Cancer Center, Birmingham, USA )
3 Dec 2016
A new spin on leukaemia therapy
Prof Armand Keating - University of Toronto, Toronto, Canada
A new spin on leukaemia therapy ( Prof Armand Keating - University of Toronto, Toronto, Canada )
3 Dec 2016
CPX-351 after stem cell transplant for elderly patients with AML
Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA
CPX-351 after stem cell transplant for elderly patients with AML ( Prof Jeffery Lancet - H. Lee Moffitt Cancer Center, Tampa, USA )
3 Dec 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation